CMBT vs ENB

CMBT presents a contradictory profile: explosive revenue growth (160% YoY) paired with a deteriorating earnings track record and poor liquidity. While the Piotroski F-Score of 6/9 indicates stable financial health, the company has missed earnings estimates in 4 consecutive quarters with a severe average surprise of -156.54%. The stock trades slightly above its Graham Number ($11.93) and significantly above its growth-based intrinsic value ($4.90), suggesting a valuation premium that is not currently supported by bottom-line performance. High leverage (Debt/Equity 2.12) and a current ratio below 1.0 create a precarious financial position despite strong operating margins.

Enbridge presents a conflicted profile with a stable Piotroski F-Score of 4/9, but significant valuation and sustainability concerns. While the intrinsic value estimate is high ($69.62), the Graham Number ($31.45) suggests the stock is trading at a steep premium to its defensive value. The most critical red flag is a payout ratio of 117.08%, indicating that dividends are currently funded by debt or cash reserves rather than earnings. Combined with a bearish technical trend (10/100) and a current price exceeding the analyst target of $51.13, the outlook is cautious.